Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2019 / N 4

Сахарный диабет 2-го типа у пациентов с хронической обструктивной болезнью легких: акцент на проблеме
В.А. Сергеева, Ю.О. Харькова

References

1. Ostroumova OD, Kochetkov AI. Chronic obstructive pulmonary disease and comorbid cardiovascular diseases. Consilium Medicum 2018;20(1):54-61 (In Russian). 2. Vertkin AL, Skotnikov AS, Tikhonovskaya EYu, Oralbekova ZhM, Gubzhokova OM. Comorbidity in patients with COPD and chronic systemic inflammation. Russian Medical Journal 2014; 22(11):811-6 (In Russian).
3 Sergeyeva VA. Arterial hypertension in patients with chronic obstructive pulmonary disease: clinical and functional relationships and possibilities of drug correction [Dissertation for the Degree of the Candidate of Medical Sciences]. Saratov, 2010. 129 p. Available from: https://dlib.rsl.ru/01004663624 Accessed 2019 Dec 12. (In Russian).
4. Manzotti E, Barclay L, Patel A, Hurst J. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Review of Respiratory Medicine 2011 Oct;5(5):647-62.
5. Barnes P. Chronic obstructive pulmonary disease. The New England Journal of Medicine 2000 Jul;343(4):269-80.
6. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B; BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012 Jul;186(2):155-61.
7. Mamillapalli C, Tentu R, Jain NK, Bhandari R. COPD and type 2 diabetes. Current Respiratory Medicine Reviews 2019;15(2):112-19.
8. Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010 Jan;33(1):55-60.
9. Wells CE, Baker EH. Metabolic syndrome and diabetes mellitus in COPD. European Respiratory Society Monograph 2013;59:117-34.
10. Kinney GL, Black-Shinn JL, Wan ES, Make B, Regan E, Lutz S, Soler X, Silverman EK, Crapo J, Hokanson JE; COPDGene Investigators. Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes Care 2014 Feb;37(2):389-95.
11. Miller J, Edwards LD, Agustí A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Vestbo J, Wouters E, Yates JC, Macnee W; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respiratory Medicine 2013 Sep;107(9):1376-84.
12. Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P, Janson C. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. International Journal of Chronic Obstructive Pulmonary Disease 2012;7:571-6.
13. Lin CS, Liu CC, Yeh CC, Chang YC, Chung CL, Lane HL, Shih CC, Chen TL, Liao CC. Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: two nationwide population-based retrospective cohort studies. PLoS One 2017 Aug;12(8):e0181815.
14. Kinney GL, Baker EH. Type 2 diabetes mellitus and chronic obstructive pulmonary disease: need for a double-pronged approach. Diabetes Management 2014;4(4):307-10.
15. Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression. The American Journal of Medicine 2010 Nov;123(11):1001-6.
16. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003 Aug;124(2):459-67.
17. Walters JA, Tan DJ, White CJ, Gibson PG, Wood‐Baker R, Walters EH. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews 2014 Sep;(9):CD001288.
18. Vozoris NT, O’Donnell DE. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Canadian Respiratory Journal 2012 May-Jun;19(3):e18-24.
19. Eisner MD, Blanc PD, Sidney S, Yelin EH, Lathon PV, Katz PP, Tolstykh I, Ackerson L, Iribarren C. Body composition and functional limitation in COPD. Respiratory Research 2007 Jan;8:7.
20. Blum A, Simsolo C, Sirchan R, Haiek S. “Obesity paradox” in chronic obstructive pulmonary disease. The Israel Medical Association Journal 2011 Nov;13(11):672-5.
21. Wu TD, Ejike CO, Wise RA, McCormack MC, Brigham EP. Investigation of the obesity paradox in chronic obstructive pulmonary disease, according to smoking status, in the United States. American Journal of Epidemiology 2019 Nov;188(11):1977-83.
22. Zewari S, Vos P, van den Elshout F, Dekhuijzen R, Heijdra Y. Obesity in COPD: revealed and unrevealed issues. Journal of Chronic Obstructive Pulmonary Disease 2017 Dec;14(6):663-73.
23. Krommidas G, Kostikas K, Papatheodorou G, Koutsokera A, Gourgoulianis KI, Roussos C, Koulouris NG, Loukides S. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. Respiratory Medicine 2010 Jan;104(1):40-6.
24. Sergeyeva VA. Three-year dynamics and unsolved problems of lipid-lowering therapy. Rational Pharmacotherapy in Cardiology 2015;11(5):504-9 (In Russian).
25. Xuan L, Han F, Gong L, Lv Y, Wan Z, Liu H, Zhang D, Jia Y, Yang S, Ren L, Liu L. Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis. Lipids in Health and Disease 2018 Nov;17(1):263.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]